Advancing In Vivo CAR-T Platforms from Preclinical Development to Clinical Translation
9:30 am - Wednesday 2nd December 2026
- Highlighting non-human primate learnings to support translational confidence and inform progression toward clinical development
- Evaluating dual-target strategies to balance effective immune modulation with the safety considerations critical for autoimmune applications
- Leveraging manufacturing capabilities and platform scalability to position in vivo CAR-T approaches for broader autoimmune disease opportunities
